I'm looking for

The Abstract Submissions for the SGO 2026 Winter Meeting are Closed

Thank you for submitting research for presentation consideration at the Society of Gynecologic Oncology (SGO) 2026 Winter Meeting, January 29-31 2026, in Olympic Valley, California. Abstract submissions are now closed. Accepted abstract submissions will be notified in November.

The Winter Meeting Abstract Review Committee will conduct a blinded review of all submissions, prioritizing clinical abstracts. Awards will be given for the best oral presentation and the best scientific poster, based on scientific content, originality, potential impact, and quality of presentation.

Submitters are encouraged to review the full SGO 2026 Winter Meeting Submission Rules and Regulations.

 

Please contact the SGO Education Department at education@sgo.org with any questions.

Category

SGO Winter Meeting Submission Rules and Regulations

Submitting authors must: 
  1. be a current student, resident or fellow as of January 1, 2025. 
  2. have substantially contributed to the work. 
  3. disclose if the abstract has been previously presented at a national or international meeting. If so, the abstract is not eligible for submission (prior presentation at regional meetings is allowed). 
  4. disclose if any of the data in the abstract has been previously presented or published. (If part of the work has been previously published, the author must declare that the work submitted contains substantial new or different data than what was previously presented. This does not make the abstract ineligible for submission. )  
  5. include the NCT# for reports on clinical trials, if applicable. 
  6. identify the Presenting Author, who agrees to attend the Winter Meeting and present the abstract, if accepted. (Changes to the presenting author may be made prior to Dec. 31, 2025.) 
  7. identify a Lead Author/Mentor, who will be notified and must complete a disclosure form before the abstract submission deadline in order for the abstract to be considered. 
Abstract submissions must clearly identify the following: 
  1. Title: title must indicate the nature of the investigation. Example: The current clinical use of HPV genotyping.  
  2. Objective(s): an introductory sentence indicating the purpose of the study 
  3. Methods: a brief description of pertinent experimental procedures, including statistical evaluation where appropriate 
  4. Results: a summary of the data 
  5. Conclusions: a statement of the conclusions 
  6. The title and abstract should omit any reference to your institution to ensure a blinded review. 
  7. Trade names should not be used. 
  8. Acceptance and decline notices will be sent in early November 2025. 
  9. A maximum of 25 authors are allowed per submission. 
  10. The character count limit of 3,000 does not include your abstract title, author string, allotted tables or graphs or spaces. 

SUBMIT ABSTRACTS